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Urea and nitrogen excretion in pediatric peritoneal dialysis The effect of nutritional status on the long-term out-
patients. come of patients with ESRD is well established [1, 2].
Background. Adequate nutrition is critical to the care of chil- Indeed, undernutrition contributes importantly to growthdren with end-stage renal disease, and failure to reach the target
failure in children with renal disease [3–8]. Deficientdietary intake is associated with growth failure. Prospective stud-
anabolism and statural growth are common in these pa-ies of urea and nitrogen output in adults have led to the deriva-
tion of quantitative relationships, which allow assessment of tients and may prove irremediable after a prolonged
dietary protein intake when only urea appearance is known. period of dialysis. Thus, great effort is devoted to ensur-
Such a clinically useful relationship has not been defined in ing delivery of targeted dietary protein and calorie intakechildren receiving chronic peritoneal dialysis (PD).
in children receiving maintenance dialysis treatments;Methods. We studied 18 pediatric PD patients (ages 0.8 to
these efforts include intensive dietary counseling and14.3 years) on 132 occasions and determined norms of urea
nitrogen appearance (UNA), total nitrogen appearance (TNA), nasogastric feedings [9, 10]. An enhanced dose of dialysis
and nonurea nitrogen appearance (NUNA). We stratified data (as Kt/Vurea) may improve protein and energy intake ason UNA, TNA, NUNA, nonprotein nitrogen appearance, and
well [11, 12].the protein equivalent of nitrogen appearance by age groups
In stable peritoneal dialysis (PD) patients, adherence(0 to 5, 6 to 10, and 11 to 15 years of age) and demonstrated
significant differences. In addition, dietary protein and energy to dietary protein instructions may be determined by
intake were measured in the outpatient setting with food scales measuring total nitrogen appearance (TNA) at steady
and dietitian interviews, and the results were stratified by age, state in dialysate and urine. While steady-state TNA is
presence of residual renal function, and recombinant human
the standard for indirect assessment of dietary proteingrowth hormone (rhGH) therapy.
intake, usually only urea nitrogen appearance (UNA) isResults. UNA (3.05 6 1.38 g/day, 103 6 42 mg/kg/day) and
TNA (4.67 6 1.86 g/day, 159 6 52 mg/kg/day) varied signifi- readily available. This has led to the derivation of quanti-
cantly between different age groups. NUNA in pediatric sub- tative relationships between total nitrogen and UNA
jects (56 6 24 mg/kg/day) was significantly greater than pre- [13–19] for adult patients with chronic renal insufficiencyviously published adult norms. A linear relationship was
(CRI) and those receiving PD. Previous studies in pediat-defined between UNA and TNA that was specific to pediatric
ric patients have focused on the use of UNA as in indica-PD patients [TNA (g/day) 5 1.26(UNA) 1 0.83]. When the
relationship was scaled to body mass, the y intercept was sig- tor of dietary protein intake [20, 21], while only prelimi-
nificantly different in the youngest subjects [TNA 5 1.03 nary data exist to establish a relationship between UNA
(UNA) 1 0.02 (weight in kg) 1 0.56 (for subjects age 0 to 5) and TNA (abstract; Edefonti, J Am Soc Nephrol 6:576,or 0.98 (for subjects age 11 to 15 or 6 to 10), r 2 5 0.91]. Dietary
1995). Nitrogen balance studies performed on childrenprotein intake was significantly greater in subjects receiving
receiving chronic PD have often been of limited size andrhGH therapy, although nitrogen excretion was unchanged.
Conclusions. Markers of protein metabolism in pediatric PD duration, resulting in incomplete stabilization of nitrogen
patients are age dependent and differ from adult values. An intake, and have not provided sufficient data to utilize urea
age-specific relationship between TNA and UNA is defined for
nitrogen and TNA interchangeably [22–24]. Thus, wepediatric subjects; it does not vary with rhGH or the presence of
sought to determine a predictable relationship betweenresidual renal function.
urea nitrogen and total nitrogen excretion to facilitate
nutritional assessment in this patient population, which
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is at greatest risk for undernutrition and growth failure.infant, child, adolescent renal failure, nitrogen, urea, protein metabo-
lism, recombinant human growth hormone. In this study, repeated measurements of urea nitrogen
and total nitrogen excretion in stable pediatric PD pa-Received for publication January 27, 2000
tients were obtained, allowing usual dietary intake in theand in revised form June 20, 2000
Accepted for publication July 5, 2000 outpatient setting. We have defined norms of urea and
nitrogen excretion for children across a wide range ofÓ 2000 by the International Society of Nephrology
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Table 1. Patient demographics Dialysis techniques
Category Chronic ambulatory PD (CAPD) and chronic cycling
Number of males/females 10/8 PD (CCPD) were performed by patients and parents.
Subjects/studies age 0–5 7/25 The dialysis prescription and choice of modality were
Subjects/studies age 6–10 3/22
based on kinetic modeling of dialysis delivery (targetSubject/studies age 11–15 8/85
Caucasian/African American/Hispanic 10/3/5 Kt/Vurea . 2.0) and adequacy of ultrafiltration. Kt/Vurea
Age years: mean6SD (range) 7.864.9 (0.8–13.9) (including dialysis 1 residual renal function) was deter-
Duration of ESRD years: mean6SD (range) 1.762 (0.1–6.0)
mined by direct measurement of 24-hour dialysate andMean serum albumin6SD 3.060.6
Subjects/studies with residual kidney urine collections and serum urea [25] and was performed
function (.200 mL urine/day) 11/30 at least quarterly. The accuracy of Kt/Vurea was assessedSubjects/studies treated with recombinant
by ensuring the completeness of collection and the con-human growth hormone 10/55
Mean weekly total Kt/Vurea 2.1960.37 sistent performance of daily PD prescription by nurse
and physician interview, review of stored data on the
automated PD cycler compared with prescribed PD vol-
ume, and occasional home visits.
ages (9 months to 14 years), stratified them by age and
have adjusted for body size. Furthermore, the results in Diet records
subjects with and without residual renal function and Parents and patients were instructed in measuring and
recombinant human growth hormone (rhGH) therapy recording food intake by an experienced pediatric renal
were compared. This large data set was used to define the dietitian. Food scales accurate to 0.1 g were provided to
relationship between urea nitrogen and total nitrogen improve the reliability of outpatient diet records; pa-
excretion for chronic PD patients of different age groups, tients and parents were instructed in their use. Three-
and normalized it to weight. Finally, we compared this day diet logs were completed at home by the subjects
relationship in pediatric PD patients with the results of or parents prior to office visits, which were timed to
prior studies in adults. coincide with urine and dialysate collections. Either the
subjects or parents were interviewed by a dietitian to
validate the diet records. Diet records were analyzed forMETHODS
protein and calorie content by dietary technicians using
Subjects the computer program Food Processor for Windows 6.0
Eighteen stable chronic PD outpatients, ages 9 months (ESHA Research, Salem, OR, USA).
to 14.3 years, were studied over 132 separate 24-hour
Diet prescriptionsperiods (mean 7.3 studies per patient, range 1 to 16).
The mean interval between studies was 38 days (range Dietary prescriptions were based on accepted age-appro-
5 to 154). Table 1 shows data for the study population priate guidelines [26]: 102 kcal/kg and 2 to 2.5 g pro-
and for age subgroups 0 to 5, 6 to 10, and 11 to 15 years. tein/kg for ages 1 to 3 years, 90 kcal/kg and 2 to 2.5 g
All subjects over six years of age attended school full protein/kg for ages 4 to 6 years, 70 kcal/kg and 2 to 2.5 g
time. The nutritional status of subjects was assessed by protein/kg for ages 7 to 10 years, and 40 to 55 kcal/kg and
clinical history, dietary history, interval growth and weight 1.5 g protein/kg for ages 11 to 18 years. Actual dietary
gain, and measurement of serum albumin. Formal an- intakes often varied widely from this regimen. Three sub-
thropometric measurements were performed quarterly jects had their diets supplemented by nasogastric feedings.
by the same dietitian. Subjects considered undernour-
Dialysate and urine collectionsished, those with declining serum albumin, and those
with the nephrotic syndrome were excluded. Patients Spent dialysate and urine were collected over a 24-hour
with intercurrent illness (including peritonitis) or hospi- period prior to office visits. Total volume was determined
talization were excluded from the study for at least three by weight (accuracy 6 10 g; Scale-tronix 4800; Wheaton,
months before repeat measurements were obtained. IL, USA) and then aliquoted for determination of total
nitrogen (Kjeldahl), urea nitrogen (urease rate conduc-
Concomitant therapy tivity), and protein (modified biuret). The reliability of
Patients received the usual therapy to prevent the met- dialysate and urine collections was assessed by a PD
abolic complications of end-stage renal disease (ESRD), nurse interview with subjects and their parents, and by
including calcium carbonate, calcitriol, erythropoietin, a review of the automated cycler program.
sodium bicarbonate, antihypertensives, multivitamins,
Calculationsand iron. Eleven patients were treated with rhGH during
part or all of the study. No subjects were studied during Both UNA and TNA were measured in 24-hour pooled
collections of dialysate and urine. Serum urea nitrogenthe first month of therapy with rhGH.
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Table 2. Comparison of nitrogen appearance in the entire study group
UNA UNA TNA TNA NUNA NUNA
g/day mg/kg/day g/day mg/kg/day g/day mg/kg/day
All subjects 3.0561.38 103642 4.6761.86 159652 1.6260.74 56624
3.17, 0.27–7.37 94, 29–265j 5.01, 0.63–9.64 150, 67–328j 1.56, 0.31–3.79 53, 10–208l
Age 0–5 years 1.4361.01 106657 2.2961.24 174668 0.8660.44 68633
1.25, 0.27–4.51f,i 83, 29–265e,g,j 2.16, 0.63–5.58f,i 153, 67–328d,g,j 0.85, 0.31–2.22f,i 64, 33–208d,h,l
Age 6–10 3.4361.00 132627 5.0261.28 195633 1.5960.54 62623
3.46, 1.74–4.99c,g 126, 91–175b,i,j 5.47, 2.80–7.17c,g 189, 139–256a,i,k 1.57, 0.59–2.85c,g 56, 33–145a,g,l
Age 11–15 years 3.4361.21 95636 5.2961.56 145645 1.8660.72 50618
3.41, 0.89–7.37c,d 88, 42–208a,f,j 5.45, 1.76–9.64c,d 139, 74–121a,f,j 1.78, 0.40–3.79c,d 49, 10–124b,d,l
(continued)
was measured only at the end of each collection. Body PD patients. Mean serum albumin was low, but typical
of our chronic PD patients. Ten subjects had residualsurface area was calculated as
kidney function (.200 mL/day) during some of the time
BSA 5 0.0235(Ht)0.42246 · (Wt)0.51456
of the study, reflected in 30 collections. Many subjects
lost residual function over months of observation. Elevenaccording to Gehan and George [27]; this formula has
been validated previously in children. Nonurea nitrogen subjects were treated with rhGH during part or all of
their study period for a total of 55 collections duringappearance (NUNA) was calculated by subtracting urea
nitrogen from total nitrogen in dialysate and urine. Non- rhGH therapy. Mean delivered dialysis dose by Kt/Vurea
was .2.1.protein nitrogen appearance (NPNA) was calculated by
The results of UNA, TNA, NUNA, PNA, NPNA, andsubtracting protein content of dialysate and urine from
PNPNA for 132 dialysate and urine collections (in thoseTNA. This calculated value allows an assessment of ni-
patients with residual urine output) are shown in Tabletrogen excretion without the potentially confounding ef-
2, expressed both as absolute daily excretion and normal-fects of dialysate and urinary protein losses. When
ized to body weight. Data are shown for the entire studysteady-state nitrogen balance is assumed, dietary protein
group and are then stratified by age group. Our subjectsintake can be estimated as the protein equivalent of
are also compared with adults previously reported bynitrogen appearance (PNA) 5 6.25 3 TNA or even
Bergstro¨m et al [18]; adult values have been divided bymore precisely as the protein equivalent of nonprotein
reported patient weight to permit comparison with pedi-nitrogen appearance (PNPNA) 5 6.25 3 NPNA. These
atric subjects. While absolute UNA and TNA (g/day) informulae were normalized to body weight.
children are lower than values reported for adults, once
Statistical methods normalized to body weight (mg/kg/day), UNA and TNA
for the entire pediatric study population did not differData are reported as mean 6 SD of the sample, me-
significantly from adult values. However, a comparisondian, and range. A comparison of data on nitrogen ap-
of each pediatric age subgroup with Bergstro¨m et al’spearance (Table 2) for the entire patient group with
data did yield significant differences in TNA and NPNApreviously published data for adults receiving chronic
for some groups (Table 2). In addition, the presence ofPD was made by Mann–Whitney nonparametric test;
residual kidney function in children was associated withcomparisons within different age subgroups were made
higher TNA [172 6 44, 173 (range 67 to 271) vs. 155 6by Kruskal–Wallis nonparametric analysis of variance.
53, 144 (74 to 328) mg/kg/day, P 5 0.02 by Mann–Comparisons of dietary intake, serum albumin, and de-
Whitney] and UNA [112 6 35, 111(29 to 193) vs. 101 6livered dialysis dose (Table 3) were also by Mann–
43, 88 (40 to 265) mg/kg/day, P 5 0.02], while therapyWhitney test and Kruskal–Wallis nonparametric analysis
with rhGH did not affect TNA or UNA.of variance (ANOVA) for multiple subgroups. The rela-
Nonurea nitrogen appearance in children [56 6 24, 51tionship between TNA and UNA was derived by linear
(10 to 208) mg/kg/day] was greater than that previouslyregression, while models incorporating weight and age
reported by Maroni, Steinman, and Mitch for adultswere obtained by ANOVA using SAS statistical soft-
[31 6 12, 31 (10 to 59) mg/kg/day, P , 0.001] and alsoware. P , 0.05 was considered significant.
varied by age as shown in Table 2 [14]. NUNA in the
youngest subjects was significantly greater than that seen
RESULTS in the subjects ages [11–15]. In subjects who still had
Characteristics of the study patients are presented in residual renal function, NUNA was not different from
Table 1. In age, ethnicity, and duration of ESRD, the that seen in subjects without continued urine output.
However, NUNA was significantly greater in subjectssubjects were similar to our entire population of chronic
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Table 2. Continued
PNA NPNA NPNA PNPNA PNPNA
g/day g/day mg/kg/day g/day g/kg/day
All subjects 29.25611.63 4.0561.71 137649 25.28610.70 0.8560.30
31.30, 3.93–60.24 4.2, 0.44–8.78 127, 43–306j 26.26, 2.73–54.87 0.79, 0.27–1.91
Age 0–5 years 14.3167.75 1.8861.11 144668 11.7566.92 0.9060.42
13.48, 3.93–34.88f,i 1.70, 0.44–4.82f,i 124, 43–306e,g,j 10.6, 2.73–30.12f,i 0.76, 0.27–1.91e,g
Age 6–10 31.3968.01 4.4561.19 172630 27.867.41 1.0860.19
34.19, 17.48–44.82c,g 4.69, 2.46–6.48c,g 169, 127–231b,i,j 29.31, 15.37–40.50c,g 1.06, 0.79–1.45b,i
Age 11–15 years 33.0869.76 4.5861.46 126641 8.62969.14 0.7860.25
34.07, 11.02–60.24c,d 4.65, 1.52–8.78c,d 119, 68–250a,f,k 29.04, 9.50–54.87c,d 0.74, 0.42–1.56a,f
Data are shown as mean 6 SD, median and range.
Comparison with ages 0–5: aP 5 not significant; bP , 0.05; cP , 0.001, by nonparametric ANOVA, Kruskal-Wallis test
Comparison with ages 6–10: dP 5 not significant; eP , 0.05; fP , 0.001
Comparison with ages 11–15: gP 5 not significant; hP , 0.05; iP , 0.001
Comparison to data of Bergstro¨m et al [18], jP 5 not significant, kP , 0.05
Comparison to data of Maroni et al [14], 31 mg/kg/day, lP , 0.001
Table 3. Comparisons of dietary intake, serum albumin and dialysis dose
Energy intake Protein intake
Serum albumin Measured total
Age kcal/kg/day kcal/kg IBW/day g/kg/day g/kg IBW/day g/dL Kt/Vurea
0–5 years 84636 86633 2.5561.19 2.6261.14 3.060.6 2.3560.82
69, 45–154d,i 74, 50–154f,i 2.30, 0.91–4.84d,h 2.56, 0.99–4.84d,g 2.9, 1.9–4.0f,g 2.15, 1.37–4.26d,g
6–10 years 56614 52617 2.0660.45 1.8860.46 3.860.3 2.5760.52
56, 35–82a,g 53, 31–82c,g 2.21, 1.31–2.78a,g 1.81, 1.14–2.78a,g 3.9, 2.8–4.6c,i 2.67, 1.81–3.51a,i
11–15 years 46620 51620 1.7760.8 1.9860.75 3.260.6 2.0860.49
44, 12–102c,d 45, 22–113c,d 1.69, 0.54–4.06b,d 1.79, 0.68–4.30a,d 3.25, 1.7–4.4a,f 2.00, 1.13–3.50a,f
Data shown as mean 6 SD, median and range.
Comparison with ages 0–5: aP 5 not significant; bP , 0.05; cP , 0.01, by nonparametric ANOVA, Kruskal-Wallis test
Comparison with ages 6–10: dP 5 not significant; eP , 0.05; fP , 0.01
Comparison with ages 11–15: gP 5 not significant; hP , 0.05; iP , 0.01
treated with rhGH than in subjects not so treated [59 6
14, 59 (34 to 95) vs. 54 6 28, 48 (10 to 208) mg/kg/day,
P 5 0.0016]. On average, 64 6 11% of total nitrogen
output and 75 6 10% of nonprotein nitrogen are ex-
creted as urea in this pediatric population.
Self-reported, measured dietary intake of energy and
protein is shown in Table 3 and is stratified by age.
Results are normalized to actual body weight and ideal
body weight (IBW) to correct for subjects who were
significantly underweight or overweight. Energy intake
was greater in the youngest subjects (age 0 to 5) than in
the oldest age group (11 to 15, P , 0.01). Protein intake
was greater in the youngest subjects when compared
with the oldest subjects (P , 0.05), but that difference
Fig. 1. Relationship of the total nitrogen appearance (TNA; g/day)
became insignificant when weight was corrected to IBW. and urea nitrogen appearance (UNA; g/day) is TNA 5 1.26 (UNA) 1
0.83.Measured dialysis delivery (Kt/Vurea) and serum albumin
were greater in the subjects aged 6 to 10 than in those
aged 11 to 15; however, dietary protein intake was not
different. Protein and energy intakes were significantly
The relationship of UNA and TNA is demonstratedgreater in subjects treated with rhGH when compared
in Figure 1. TNA was closely correlated with UNA inwith subjects who did not receive the therapy [2.15 6
132 paired measurements with TNA (g/day) 5 1.260.77, 2.21 (0.82 to 4.16) vs. 1.60 6 0.86, 1.66 (0.54 to 4.84)
(UNA) 1 0.83, with r 2 5 0.88 and P , 0.0001. Theg/kg/day and 57 6 20, 53 (25 to 131) vs. 46 6 30, 40
relationship between UNA and TNA was compared to(12 to 154) kcal/kg/day, P , 0.001]. This difference was
maintained even when dietary intake was scaled to IBW. two previously published adult series in Figure 2. The
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DISCUSSION
In this study, we sought to define a relationship be-
tween measures of nitrogen excretion (UNA, TNA, and
NPNA) in pediatric PD patients. Furthermore, our large
data set and wide age range allowed us to compare mark-
ers of protein metabolism between different age groups
and published adult values. Significant differences in
UNA, TNA, NUNA, PNA, NPNA, and PNPNA were
demonstrated that define norms of nitrogen excretion
for these age groups. Differences noted between UNA
and TNA in our subjects and previously reported values
from adult studies should be interpreted cautiously, as
dietary intakes appear to have differed importantly and
there are methodologic differences in study design and
Fig. 2. Comparison of relationship of TNA and UNA in pediatric sample collection.
subjects with published formulae for adults. Symbols are: (___) pediatric
Nonurea nitrogen excretion in children receiving PDdata set; (- - -) Kopple et al [16]; (· · ·) Bergstro¨m et al [18].
was significantly greater than that reported by Maroni,
Steinman, and Mitch and varied with age and with rhGH
therapy [14]. This result is all the more striking in that
relationship defined in our subjects was similar to those we did not account for fecal nitrogen as Maroni, Stein-
obtained by Kopple, Gao, and Qing [16] and Bergstro¨m man, and Mitch did; we expect that the difference would
et al [18]. In each case, the slope of the defined lines fell have been even greater had fecal nitrogen been included.
The larger NUNA in young children (and even more sowithin the 95% CI of our data, but the intercept was
in those receiving rhGH) when compared with Maroni,significantly different. Furthermore, the relationship be-
Steinman, and Mitch’s adult subjects may represent atween TNA and UNA did not vary significantly with the
developmental alteration in urea metabolism, which isuse of rhGH or the presence of residual kidney function
unique to growing children.in our study population.
When the effects of rhGH and residual kidney func-In our pediatric study population, TNA could be even
tion were assessed on markers of protein metabolism, wemore precisely predicted from UNA when normalized
found that subjects with residual renal function excretedto body weight [TNA 5 1.07 (UNA) 1 0.023 (weight in
more nitrogen, whether measured as UNA or TNA.kg) 1 0.67, r 2 5 0.90 and P , 0.0001]. This relationship
NUNA was not affected by residual urine output. It iscould be further refined by incorporating age into the
possible the increased nitrogen excretion reflects aanalysis, which allowed us to define age-specific con-
slightly higher nitrogen intake in those subjects with re-stants [TNA 5 1.03 (UNA) 1 0.02 (weight) 1 0.56 (for
sidual renal function, although the difference in DPI wassubjects age 0 to 5) or 0.98 (for subjects age 11 to 15 or
not detected by diet history. This would be consistent6 to 10), r 2 5 0.91]. The constant for subjects age 0 to
with data from Caravaca, Arrobas, and Dominguez [28].5 (0.56) was significantly different from that for the older
Growth hormone therapy did not change total nitrogen
subjects (0.98) by the Bonferroni (Dunn) t-test.
excretion, although a larger amount was excreted as non-
The dietary protein intake (DPI) of stable pediatric urea nitrogen.
patients can be estimated from the PNA. From UNA, When normalized to body mass, children in our study
PNA for this population can be calculated as follows: ate more protein than adults in previously published
PNA (g/day) 5 6.69 (UNA) 1 0.14 (wt) 1 4.19. series [16, 18]. Subjects attained their age-specific goal
Nonprotein nitrogen appearance may be a more useful for dietary protein intake, but the younger subjects were
measure of nitrogen output and allow a more meaningful often below their goal for dietary energy intake despite
estimate of protein intake, since it avoids the confound- the use of supplemental nasogastric feeding. Subjects
ing effect of dialysate and urine protein losses. As ex- ages 6 to 10 had the highest Kt/Vurea and serum albumin
pected, NPNA also closely correlated with UNA (with values. However, this could not be directly related to
NPNA 5 1.18 (UNA) 1 0.45, r 2 5 0.90, P , 0.0001). improved dietary intake of protein; the DPI for this
When normalized to body mass, the relationship became age group was not significantly different from the other
NPNA 5 1.04 (UNA) 1 0.018 (weight) 1 0.33, r 2 5 subjects, and all children had adequate DPI and Kt/Vurea.
0.92 and P , 0.0001. The relationship between NPNA Subjects treated with growth hormone had signifi-
and UNA did not vary significantly with the use of rhGH cantly greater DPI, although no greater nitrogen excre-
tion. This implied difference in dietary nitrogen utiliza-or the presence of residual kidney function.
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tion suggests an anabolic state from rhGH therapy, but in whom nitrogen appearance may exceed protein in-
take, and likewise may be invalid in the setting of rapidthe current study design does not permit a firm conclusion.
One hundred thirty-two simultaneous measurements anabolism where nitrogen accretion may represent a
greater fraction of dietary nitrogen intake. We have as-of nitrogen and urea allowed us to conclude that urea
nitrogen excretion in dialysate and urine can be used to sumed that even in growing children, daily nitrogen ac-
cretion is small enough so that over a 24-hour observa-predict dialysate and urine total nitrogen excretion in
pediatric patients in clinical situations where actual mea- tion period, it will not invalidate an assumption regarding
urea and TNA. The effect of anabolism may be moresurement of nitrogen is impractical. We have defined a
reliable relationship between UNA and TNA and body significant in our subjects treated with rhGH, even
though they were all studied after they had stabilized onmass in this population. Furthermore, we have stratified
our results by subject age and demonstrated that the therapy for at least one month.
In summary, we have defined a relationship betweenconstant (y intercept) of the equation relating UNA and
TNA is age dependent, implying a fixed difference in nitrogen output and urea nitrogen excretion in children
receiving chronic PD that differs importantly from thatnitrogen excretion in subjects age five and under. The
relationship does not vary with residual renal function defined for adults. This should prove useful for future
studies of kinetic modeling and adequacy of pediatricor rhGH therapy.
The relationship defined between UNA and TNA was PD. As well, it may provide a clinically useful tool to
allow an estimation of dietary protein intake; with it,compared with those defined by Kopple et al [16] and
Bergstro¨m et al [18] in adult subjects. In each case, the one should be able to identify and address inadequate
dietary intake early, rather than waiting for the insidiousslope of the relationship fell within the 95% confidence
interval of our data, but the y intercept (constant) was development of malnutrition or growth failure.
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between our study and those of Kopple et al [16] and
Formulae for calculations
Bergstro¨m et al [18]. Our pediatric subjects could not
TNA (g/day) 5 dialysate nitrogen (g/day) 1 urine nitrogenbe confined to the clinical research center for 24.8 6 9.5
(g/day)
days, as in the former study, or 8 to 17 days, as in the UNA (g/day) 5 dialysate urea (g/day) 1 urine urea (g/day)
For anuric patients, urine nitrogen and urine urea 5 0latter. Thus, formal nitrogen balance studies could not be
NUNA (g/day) 5 TNA 2 UNAperformed, and while dietary guidance and instructions
NPNA (g/day) 5 TNA 2 [dialysate protein (g/day 1 urine protein
were given regularly, subjects ingested their usual diet (g/day)]/6.25
For anuric patients urine protein 5 0during all dialysate and urine collection periods. As such,
PNA (g/day) 5 6.25(TNA)our study provides a more realistic assessment of typical
PNPNA (g/day) 5 6.25(NPNA)
nitrogen excretion, yet we are limited in our ability to PNPNA (g/kg/day) 5 6.25(NPNA)/weight in kg
correlate nitrogen excretion with actual protein ingested.
The assumption that nitrogen appearance is an accu- Representative calculation
A three-year-old (11.2 kg) male with ESRD secondary to obstructiverate reflection of nitrogen intake depends on subjects
uropathy who maintains urine output through chronic PD grows slowlyremaining in approximate nitrogen balance; in stable
over several months. Dietary protein prescription is 2 to 2.5 g/kg/day,
outpatients, net daily accretion of nitrogen is relatively while dietary records from home suggest protein intake of 40 to 50
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